MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 140 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $397,083 | +5.6% | 2,719 | -53.0% | 0.05% | +75.9% |
| Q3 2022 | $376,000 | +57.3% | 5,789 | +73.1% | 0.03% | +45.0% |
| Q2 2022 | $239,000 | -34.3% | 3,345 | -26.7% | 0.02% | -54.5% |
| Q3 2021 | $364,000 | -67.4% | 4,564 | -60.2% | 0.04% | -74.3% |
| Q2 2021 | $1,118,000 | +26.9% | 11,478 | +52.3% | 0.17% | -11.4% |
| Q1 2021 | $881,000 | -25.1% | 7,535 | -28.8% | 0.19% | -47.8% |
| Q4 2020 | $1,177,000 | – | 10,588 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |